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uplications and overexpression of the proteolipid
protein (PLP) gene are known to cause the dysmy-
elinating disorder Pelizaeus-Merzbacher disease (PMD).
To understand the cellular response to overexpressed PLP
in PMD, we have overexpressed PLP in BHK cells and
primary cultures of oligodendrocytes with the Semliki
Forest virus expression system. Overexpressed PLP was routed
to late endosomes/lysosomes and caused a sequestration
of cholesterol in these compartments. Similar results were
seen in transgenic mice overexpressing PLP. With time, the
endosomal/lysosomal accumulation of cholesterol and PLP
led to an increase in the amount of detergent-insoluble
cellular cholesterol and PLP. In addition, two ﬂuorescent
D
 
sphingolipids, BODIPY–lactosylceramide and –galactosyl-
ceramide, which under normal conditions are sorted to the
Golgi apparatus, were missorted to perinuclear structures.
This was also the case for the lipid raft marker gluco-
sylphosphatidylinositol–yellow ﬂuorescence protein, which
under normal steady-state conditions is localized on the
plasma membrane and to the Golgi complex. Taken together,
we show that overexpression of PLP leads to the formation
of endosomal/lysosomal accumulations of cholesterol and
PLP, accompanied by the mistrafﬁcking of raft components.
We propose that these accumulations perturb the process
of myelination and impair the viability of oligodendrocytes.
 
Introduction
 
Myelin proteolipid protein (PLP)* is the major membrane
protein of central nervous system (CNS) myelin and its ex-
pression is largely limited to oligodendrocytes. This protein
has several interesting features. It spans the membrane four
times and is highly hydrophobic with 
 
 
 
50% hydrophobic
amino acids. The protein is covalently attached to several
acyl chains and interacts with cholesterol (Weimbs and Stoffel,
1992; Simons et al., 2000). The association of PLP with
cholesterol and galactosylceramide-enriched membrane
domains, so-called myelin rafts, during biosynthetic transport
in primary cultures of oligodendrocytes may be critical for
the correct sorting of PLP and the assembly of myelin in the
CNS (Simons et al., 2000). Lipid rafts are cholesterol- and
sphingolipid-rich membrane domains that form platforms
for specific proteins and regulate, for example, intracellular
membrane transport and cell signaling (Simons and Ikonen,
1997; Brown and London, 2000
 
).
 
 We have previously pro-
posed that PLP-containing myelin rafts represent specialized
forms of lipid rafts, characterized by their unique subset of
sphingolipids, galactosylceramide and sulfatide (Simons et
al., 2000). Whereas cholesterol–sphingolipid rafts have been
isolated based on their insolubility in the detergents Triton
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X-100 and CHAPS, myelin rafts containing PLP can only
be recovered from the CHAPS-insoluble membrane fraction
(Pereyra et al., 1988; van der Haar et al., 1998; Brown and
Rose, 1992; Kim et al., 1995; Krämer et al., 1997; Simons et
al., 2000). Although the exact role of PLP in myelin remains
undefined, it is known to be associated with human disease.
In humans, a variety of mutations, including missense muta-
tions, deletions, and duplications, of the PLP gene are
known to cause the dysmyelinating disorders Pelizaeus-
Merzbacher disease (PMD) and spastic paraplegia (Garbern
et al., 1999). Gene duplications of the human PLP locus are
responsible for the majority of cases of PMD and lead to en-
hanced expression of the PLP protein (Hodes and Dlouhy,
1996). The cellular mechanism of dysmyelination caused by
mutations of the PLP gene has only been studied in detail
for the missense mutations (Gow and Lazzarini, 1996). This
work has shown that most point mutations lead to accumu-
lation of the protein in the ER, presumably due to its mis-
folding (Gow and Lazzarini, 1996; Gow et al., 1998).
Transgenic mice harboring additional copies of the wild-
type PLP gene have demonstrated a premature arrest of myelin-
ation and, at higher PLP gene dosage, abnormal oligodendro-
cyte cell death (Kagawa et al., 1994; Readhead et al., 1994).
However, the molecular pathology of PLP overexpression has
remained obscure. In the present study, we have studied the
overexpression of PLP in BHK cells, cultured oligodendro-
cytes, and transgenic mice. We demonstrate the abnormal ac-
cumulation of PLP, cholesterol, and other raft components in
the late endosomal/lysosomal compartment and suggest that
the mistrafficking of these myelin components are involved
in the pathology associated with PLP overexpression.
 
Results
 
Overexpression of PLP leads to endosomal/lysosomal 
cholesterol accumulation in BHK cells
 
To analyze the general trafficking behavior of newly synthe-
sized PLP, we used BHK cells, which do not contain endoge-
nous PLP but are often used in trafficking studies. We tran-
siently transfected the cDNA encoding for PLP or PLP
containing a myc tag at its COOH terminus into BHK cells
and analyzed its distribution by immunofluorescence micros-
copy at various times after transfection. We found that the
protein was exported from the ER (unpublished data) and, at
time points early after transfection (up to 
 
 
 
14 h), was mainly
found in the Golgi region and at the plasma membrane (un-
published data). At later time points after transfection, PLP
accumulated in the endosomal–lysosomal system, as shown
by colocalization with the fluid-phase marker rhodamine–
dextran (Fig. 1 a). Cells were labeled with different markers of
the endosomal–lysosomal system to determine the exact sub-
cellular localization of PLP. We found no overlap between
PLP–myc and early endosomal antigen 1 (EEA1), a marker of
early endosomes (Fig. 1 b), or between PLP and transferrin–
rhodamine, a marker of recycling endosomes (Fig. 1 c). In
contrast, PLP colocalized with lysobisphosphatidic acid
(LBPA), which localizes to late endosomes (Fig. 1 d). The
presence of PLP within late endosomes/lysosomes is consis-
tent with earlier reports (Gow et al., 1994; Sinoway et al.,
1994; Kalway et al., 1997; Krämer et al., 2001).
Cholesterol is not uniformly distributed within the endoso-
mal–lysosomal system. It is enriched within early endosomes
and recycling endosomes and relatively depleted from late en-
dosomes and lysosomes (Brotherus and Renkonen, 1977;
Hornick et al., 1997; Mukherjee et al., 1998; Gagescu et al.,
2000; Kobayashi et al., 2001; Lusa et al., 2001; Nichols et al.,
2001). We have previously shown that PLP specifically associ-
ates with cholesterol (Simons et al., 2000). We therefore ex-
amined whether the accumulation of PLP within late endo-
somes/lysosomes causes a redistribution of cellular cholesterol.
To test this hypothesis, BHK cells were transfected with PLP–
myc and the subcellular distribution of cholesterol was moni-
tored with filipin, an antibiotic that specifically binds to free
cholesterol. We found that in BHK cells, PLP–myc showed a
remarkable colocalization with cholesterol (Fig. 2 a). Co-local-
ization of PLP–myc and cholesterol was also observed in cells
Figure 1. PLP localizes to late endosomes/lysosomes 
in BHK cells. (a) BHK cells were transfected with PLP 
or myc-tagged PLP for 24 h and incubated with 
rhodamine–dextran for 2 h at 37 C during the last 2 h 
of transfection. Cells were fixed and labeled with 
monoclonal anti-myc or polyclonal anti-PLP antibod-
ies (left) to visualize PLP. Rhodamine–dextran is 
shown in the middle. In the merged image (right), 
yellow indicates colocalization of PLP and 
rhodamine–dextran. (b) BHK cells were transfected 
with myc-tagged PLP, fixed, and double labeled with 
monoclonal anti-myc antibody to visualize PLP (left) 
and polyclonal anti-EEA1 to resolve early endosomes 
(middle). (c) PLP-transfected BHK cells were incubated 
with rhodamine–transferrin (middle) for 1 h at 37 C 
as a marker for recycling endosomes and analyzed by 
immunofluorescence for PLP (left). (d) PLP-transfected 
BHK cells were fixed and double labeled with poly-
clonal anti-PLP antibody to visualize PLP (left) and 
with a monoclonal antibody against LBPA to resolve 
late endosomes (middle). In the merged image (right), 
yellow indicates colocalization of PLP and LBPA. 
Bars, 10  m. 
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that had been incubated during the time of transfection with
medium containing lipoprotein-deficient serum, indicating
that the cholesterol was from a cellular source (unpublished
data). After a 2-h uptake of dextran, the cholesterol-loaded
vesicles were identified as endosomes/lysosomes (Fig. 2 a). To
analyze whether the redistribution of cellular cholesterol cor-
relates with PLP expression levels, we took advantage of the
Semliki Forest virus (SFV) vector. The SFV expression system
is ideally suited for this purpose, as infected cells synthesize a
synchronized wave of protein that can be followed at various
times after infection (Liljeström and Garoff, 1991). Infection
of BHK cells with SFV-PLP
 
–
 
myc or SFV-PLP resulted in the
infection of 
 
 
 
80% of cells. When cells infected with SFV-
PLP–myc were fixed 5 h after infection, PLP was observed
within the Golgi region and at the plasma membrane in most
cells (unpublished data). 10 h after infection, PLP was distrib-
uted in intracellular vesicles throughout the cell (Fig. 2 b). 20
h after infection, the vesicles appeared enlarged and many of
them exhibited a perinuclear localization (Fig. 2 c). These ves-
icles were labeled with rhodamine–dextran that was allowed
to endocytose for 2 h, but did not colocalize with dextran that
had been internalized for only 10 min, thus identifying the la-
beled structures as late endosomal/lysosomal organelles (un-
published data). Filipin staining demonstrated a striking colo-
calization of PLP with cholesterol (Fig. 2 c). Quantitative
analysis indicated that 78% of the cells that were infected with
SFV-PLP
 
–
 
myc for 20 h exhibited intracellular accumulation
of cholesterol and PLP (
 
 
 
100 cells examined). Similar results
were observed in cells that had been infected with SFV-PLP
lacking a myc tag (Fig. 2 d). In contrast, cells that had been
infected by a control virus expressing green fluorescence pro-
tein (SFV-GFP) or a virus expressing the myelin oligoden-
drocyte glycoprotein (SFV-MOG) did not accumulate
cholesterol (unpublished data). This result shows that overex-
pression of PLP induces an accumulation of cholesterol in late
endosomes/lysosomes of BHK cells.
 
Accumulation of PLP and cholesterol in the endosomal 
system is accompanied by increased insolubility 
in CHAPS
 
We have previously shown that PLP associates in the Golgi
complex with a detergent-insoluble membrane fraction (my-
elin rafts) in primary cultures of oligodendrocytes, but not
in BHK cells (Simons et al., 2000). We analyzed whether
PLP becomes detergent insoluble when it accumulates with
cholesterol in late endosomes/lysosomes. BHK cells were in-
fected with SFV containing PLP–myc for 5, 10, or 20 h, and
then cells were extracted for 30 min on ice with 20 mM
Figure 2. Targeting of PLP to late endosomes/lysosomes leads to 
cholesterol accumulation. (a) BHK cells were transfected with PLP–
myc and, after 24 h, incubated with rhodamine–dextran (red) for 2 h 
at 37 C. Immunofluorescence was performed to analyze for PLP 
(green). Cholesterol was labeled with filipin (blue). (b–d) BHK cells 
were infected with SFV-PLP–myc (b and c) or SFV-PLP (d), fixed 10 
(b) or 20 h (c and d) after infection, and analyzed by immunofluores-
cence for PLP (red) and cholesterol (blue). Insets represent a 
magnification of the region indicated. In the merged image, pink 
indicates colocalization of PLP and cholesterol. Bars, 10  m.
Figure 3. PLP associates with lipid rafts in BHK cells after increasing 
expression times. (a) BHK cells were infected with SFV-PLP–myc. 
At 5, 10, or 20 h after infection, cells were extracted with 20 mM 
CHAPS for 30 min at 4 C and centrifuged for 30 min at 14,000 g. 
Detergent-insoluble proteins in the pellet (I) and the detergent-
soluble proteins in the supernatant (S) were resolved on SDS-PAGE 
followed by Western blotting. (b) BHK cells were infected with 
SFV-PLP–myc. 20 h after infection, the cells were treated with 10 
mM m Cd or left untreated, extracted with CHAPS, and floated in a 
density gradient. Six fractions were collected from the top. The top 
fraction represents the low-density, CHAPS-insoluble membrane 
fraction, whereas the fractions of high density contain CHAPS-soluble 
membrane. (c) BHK cells were infected with wild-type SFV. 5 or 20 
h after infection, cells were processed as described in a. The pellet 
(I) and supernatant (S) were analyzed by Western blotting for the 
viral spike protein E2. 
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CHAPS. Detergent-soluble and -insoluble material was sep-
arated by centrifugation at 14,000 
 
g
 
 for 30 min. As shown
previously, 5 h after infection, when PLP was found in the
Golgi complex and at the plasma membrane, it was largely
soluble in CHAPS (Fig. 3 a). However, 20 h after infection,
when PLP accumulates with cholesterol in late endosomes/
lysosomes, at least 50% of PLP was recovered from the
CHAPS-insoluble membrane fraction (Fig. 3 a). To exclude
that detergent insolubility was due to aggregation of the pro-
tein rather then association with lipid rafts, we analyzed the
distribution of PLP on a flotation gradient. The CHAPS ex-
tract was adjusted to 40% Optiprep and loaded at the bot-
tom of a step gradient (40, 30, and 0%). After centrifuga-
tion, six fractions were collected and the localization of PLP
was determined. The majority of PLP was recovered from
the top of the gradient in the low-density, detergent-insolu-
ble membrane fraction (Fig. 3 b). To analyze whether this
was dependent on the association with cholesterol, the cells
were extracted with 10 mM methyl-
 
 
 
-cyclodextrin (m
 
 
 
Cd)
for 30 min at 37
 
 
 
C, a procedure that reduces cholesterol lev-
els of BHK cells to 
 
 
 
40% of normal levels (Keller and Si-
mons, 1998), before detergent extraction. Depletion of cel-
lular cholesterol caused a shift of a significant amount of
PLP toward fractions of higher density (Fig. 3 b). To rule
out the possibility that raft association at late postinfection
times was due to an artifact caused by the viral expression
system, we determined the raft association of the viral spike
protein E2, 5 and 20 h after infection. In contrast to the ob-
servation with PLP, the amount of E2 recovered from the
CHAPS-insoluble membrane fraction did not increase 20 h
after infection, as compared with 5 h (Fig. 3 c).
Next, we analyzed whether the formation of rafts in late
endosomes/lysosomes changes the amount of raft-associated
cellular cholesterol in BHK cells. BHK cells were infected
with SFV-PLP–myc or were left uninfected, and 20 h after
infection, the raft association of cholesterol was determined
by extracting with 20 mM CHAPS. Detergent-soluble and
-insoluble lipids were quantified from TLC plates. 25%
(
 
 
 
6%, 
 
n
 
 
 
  
 
3) of cellular cholesterol was CHAPS-insoluble
in uninfected cells. A dramatic increase of CHAPS-insoluble
cholesterol was observed in cells that had been infected with
SFV-PLP–myc (50 
 
  
 
7%, 
 
n
 
 
 
  
 
3). Cells infected by a con-
trol virus expressing GFP (SFV-GFP) contained only 28%
(
 
 
 
4%, 
 
n
 
 
 
  
 
2) of CHAPS-insoluble cholesterol, arguing
against an effect mediated by the viral expression system.
 
Effect of endosomal accumulation of cholesterol and 
PLP on cellular cholesterol homeostasis
 
The redistribution of cellular cholesterol to the degradative
compartment of the endosomal system may have important
consequences for cellular cholesterol homeostasis. We there-
fore analyzed the effect of PLP expression on total choles-
terol levels, cholesterol efflux, and de novo cholesterol syn-
thesis in BHK cells. We found that total cholesterol levels
were not changed (unpublished data). Cholesterol biosyn-
thesis was analyzed by incubating cells infected with SFV-
PLP–myc or SFV-GFP 14 h after infection for 4 h with
[
 
14
 
C]acetate. After a 2-h chase, [
 
14
 
C]cholesterol levels were
quantified from TLC plates. We did not observe a difference
between cells infected with SFV-PLP
 
–
 
myc and cells infected
with SFV-GFP (unpublished data). To evaluate the choles-
terol efflux from the plasma membrane, we labeled cells for
24 h with [
 
14
 
C]cholesterol in lipoprotein-deficient medium,
infected the cells with SFV-PLP–myc or SFV-GFP for 20 h
in the absence of label, and extracted with m
 
 
 
Cd. We used a
30-min incubation with 10 mM m
 
 
 
Cd on ice, which ex-
tracted 26.8 
 
 
 
 3% (
 
n
 
 
 
  
 
9) of the cholesterol in uninfected
cells. 27.1 
 
  
 
2% (
 
n
 
 
 
  
 
3) of the cholesterol was removed
from cells that had been infected with SFV-GFP. In cells ex-
pressing PLP, a small reduction in cholesterol efflux was ob-
served (20.2% 
 
  
 
2.2%, 
 
n
 
 
 
  
 
9). Because cholesterol is redis-
tributed to late endosomes/lysosomes while total cholesterol
levels remain unchanged, there may be less cholesterol avail-
able for extracellular acceptors at the plasma membrane in
this latter case.
 
Accumulation of PLP and cholesterol in the endosomal 
system impairs the trafficking of raft components
 
Having shown that PLP induces redistribution of cellular
cholesterol to late endosomes/lysosomes, we tested whether
this affects the sorting of other (raft) lipids. To monitor the
trafficking of sphingolipids, we added BODIPY-labeled lip-
ids to the cells. It has been shown previously that BODIPY–
lactosylceramide or –galactosylceramide are taken up by cells
and transferred to the Golgi apparatus (Puri et al., 1999). In
several lysosomal storage diseases, however, these lipids are
rerouted to the late endosomes/lysosomes (Puri et al., 1999).
We therefore analyzed how these lipids are transported in
cells that express PLP. BHK cells were infected with SFV-
PLP
 
–
 
myc, and 16–20 h after infection, BODIPY-labeled
lipids were added to the cells as BSA complexes for 1 h at
37
 
 
 
C, and internalization was allowed to proceed for 90
min. After “back exchange” (see Materials and methods) of
Figure 4. Increased expression of PLP changes the normal 
distribution of BODIPY–lactosylceramide and –galactosylceramide. 
(a–d) BHK cells were left uninfected (a and c) or were infected with 
SFV-PLP–myc for 16 h (b and d). BODIPY-labeled lipids were added 
to the cells as BSA complexes for 1 h at 37 C, and then lipids were 
washed away and internalization was allowed to proceed for 90 
min. After “back exchange” (see Materials and methods) of the 
lipids at 12 C, the distribution of the lipid was monitored. Distribution 
of BODIPY–lactosylceramide is shown in uninfected cells (a) and 
infected cells (b). Distribution of BODIPY–galactosylceramide is 
shown in uninfected (c) and infected cells (d). Bars, 10  m. 
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the lipids at 12
 
 
 
C, the distribution of the labeled lipid was
monitored. As previously shown, both BODIPY–galactosyl-
ceramide and –lactosylceramide distributed to the Golgi re-
gion in uninfected cells (Fig. 4, a and c). In cells infected
with SFV-PLP–myc, however, both lipids were found in a
perinuclear location in enlarged vesicles within the cell (Fig.
4, b and d). These results demonstrate that expression of
PLP in BHK cells alters the trafficking of both cholesterol
and fluorescent sphingolipids. One consequence of this
might be an altered trafficking of lipid rafts. As a marker for
lipid rafts, we used yellow fluorescence protein (YFP) fused
to a glucosylphosphatidylinositol (GPI) anchor (GPI–YFP;
Keller et al., 2001). In BHK cells, GPI–YFP is mainly found
at the plasma membrane (Fig. 5 a). When GPI–YFP and
PLP were coexpressed in BHK cells, the localization of GPI–
YFP was completely altered and both proteins showed a
complete colocalization (Fig. 5 c). A similar redistribution of
GPI–YFP was observed when GPI–YFP-expressing cells
were treated with the drug U18666A, a hydrophobic amine,
which induces late endosomal/lysosomal cholesterol accu-
mulation by inhibition of cholesterol mobilization (Liscum,
2000; Fig. 5 b). Taken together, we conclude that the trap-
ping of cholesterol by overexpressed PLP in the endosomal–
lysosomal system induces the missorting of raft membrane
components.
This could possibly lead to a perturbation of endosomal
compartments. To assess whether early and late endosomal
compartments mix, cells were infected with SFV-PLP–myc,
and 20 h after infection, double immunofluorescence with
EEA1 and LBPA was performed. Both markers remained
separated, indicating that early and late endosomes did not
mix (Fig. 6 a). Next, we analyzed whether the mannose-
6-phosphate receptor (M6PR), which mostly resides in the
TGN in BHK cells, is displaced into late endosomes, as it is
in Niemann-Pick type C (NPC) cells or upon treatment
with U18666A (Kobayashi et al., 1999). Cells were infected
and the distribution of the M6PR was compared with
LBPA. Likewise, immunofluorescence microscopy revealed
that M6PR and LBPA remained largely separated (Fig. 6 b).
Our results suggest that the separation of late endosomes/ly-
sosomes from early endosomes and the TGN is not altered
by the expression of PLP in BHK cells.
 
Overexpression of PLP leads to endosomal 
accumulation of PLP and cholesterol in 
oligodendrocytes
 
Because the pathology of PLP overexpression is mediated by
oligodendrocytes in the CNS, it is important to analyze the
trafficking of PLP in these cells. In primary cultures of oligo-
dendrocytes, endogenous PLP is incorporated into choles-
terol- and galactosylceramide-enriched membrane domains
(myelin rafts) and is transported to the plasma membrane
(Simons et al., 2000). As shown previously, a fraction
of PLP colocalizes with lysosome-associated membrane pro-
tein 1 
 
(
 
LAMP-1), a marker for late endosomes/lysosomes
(Krämer et al., 2001; unpublished data). To investigate the
fate of overexpressed PLP, primary cultures of oligodendro-
cytes were infected with SFV-PLP–myc to distinguish it
from endogenous protein. We found that 8 h after infection,
the myc-tagged PLP was not transported out to the distal
part of the processes, but was found in vesicles in the cell
body and proximal part of the processes (Fig. 7 a). When
oligodendrocytes were double labeled for PLP–myc and cal-
nexin, no colocalization was observed (Fig. 7 b), ruling out
the possibility that overexpressed PLP was trapped in the
ER. Instead PLP–myc colocalized with rhodamine–dextran
that had been internalized for 2 h, identifying the vesicles as
part of the endosomal–lysosomal system (Fig. 7 a). Label-
ing of SFV-PLP–myc-infected oligodendrocytes with filipin
demonstrated colocalization of overexpressed PLP and cho-
lesterol, which was drastically pronounced 16 h after infec-
tion (Fig. 7 c). Quantitative analysis indicated that 82% of
the cells infected with SFV-PLP–myc for 16 h exhibited
colocalization of cholesterol and PLP (
 
 
 
100 cells exam-
ined). To analyze whether the myc tag interfered with the
normal trafficking behavior of PLP, we infected oligoden-
drocytes with SFV-PLP. To minimize the staining from en-
Figure 5. Expression of PLP in BHK cells affects the sorting of 
GPI–YFP. (a) BHK cells were transfected with GPI–YFP and, after
24 h, were fixed and analyzed by immunofluorescence. (b) Cells 
were transfected with GPI–YFP, incubated for 24 h in the presence 
of 10  g/ml U18666A, fixed, and analyzed by immunofluores-
cence. (c) BHK cells were cotransfected with PLP and GPI–YFP and 
analyzed after 24 h by immunofluorescence for PLP (red) and
GPI–YFP (green). In the merged image, yellow indicates colocaliza-
tion of PLP and GPI–YFP. Bars, 10  m.
Figure 6. Increased expression of PLP does not disturb endosomal 
compartmentalization. BHK cells were infected with SFV-PLP–myc. 
20 h after infection, cells were fixed and double labeled with a 
monoclonal antibody against LBPA (green), to label late endosomes, 
and a polyclonal antibody against EEA1 (a, red) or M6PR (b, red). 
Neither marker colocalizes with late endosomes. Bars, 10  m. 
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dogenous protein, we used a 10-fold higher dilution than
usual of the PLP antibody for immunofluorescence analysis.
16 h after infection, accumulation of cholesterol and PLP
was observed as in the cells expressing PLP–myc (unpub-
lished data). To analyze whether overexpression of any my-
elin protein leads to endosomal/lysosomal accumulation,
oligodendrocytes were infected with SFV-MOG for 16 h.
We found that MOG was transported to the distal processes
and the cells did not accumulate intracellular cholesterol
(Fig. 7 d). These results suggest that overexpression of PLP
in oligodendrocytes causes accumulation of PLP and seques-
tration of cholesterol in the endosomal–lysosomal system as
observed in BHK cells.
 
Overexpressed PLP does not associate with myelin 
rafts during biosynthetic transport, but forms raft 
aggregates in the endosomal system
 
Normally, the majority of PLP is incorporated into myelin
rafts and is subsequently transported to and retained in my-
elin. We therefore determined the association of overex-
pressed PLP with myelin rafts. Oligodendrocytes were in-
fected with SFV-PLP–myc, and 8 h after infection, the cells
were extracted with 20 mM CHAPS followed by density
gradient centrifugation. PLP–myc was mainly recovered
from the fractions of higher density, indicating that exoge-
nous PLP does not associate with myelin rafts (Fig. 8). In
contrast, and as shown previously, endogenous PLP and its
smaller isoform DM20 were predominantly found in the
low-density, detergent-insoluble membrane fraction (Fig.
8). It is possible that exogenous overexpressed PLP does not
associate with rafts during biosynthetic transport, because
rafts are saturated with endogenous PLP. To investigate this
possibility, we expressed PLP and PLP–myc using the SFV
expression system in immortalized oligodendroglial precur-
sor cells. These cells do not synthesize endogenous PLP, but
they express significant amounts of myelin lipid (Jung et al.,
1995). We found that at 8 h after infection, PLP and PLP–
myc were incorporated to the same extent (
 
 
 
40–50%, 
 
n
 
 
 
 
Figure 7. Exogenously expressed PLP is not transported to the 
processes but accumulates cholesterol in primary cultures of 
oligodendrocytes. (a) Oligodendrocytes were infected with SFV 
containing myc-tagged PLP and incubated with rhodamine–dextran 
for 2 h at 37 C during the last 2 h of infection. 8 h after infection, cells 
were fixed and processed for immunofluorescence. Exogenous PLP 
(green) is mainly found in the cell body. The panels at the right show 
the cell body at lower exposure. Colocalization of PLP (green) and 
rhodamine–dextran (red) is shown in the merged image as yellow. (b) 
Oligodendrocytes were infected with SFV containing myc-tagged 
PLP, and 8 h after infection, cells were fixed and processed for 
immunofluorescence for PLP (green) and calnexin (red). (c) Oligoden-
drocytes were infected with SFV containing myc-tagged PLP, and
16 h after infection, cells were fixed and processed for immunofluo-
rescence for PLP (red) and cholesterol (blue). The region indicated in 
the upper panel is shown below at a higher magnification. Colocal-
ization of PLP and cholesterol is shown in the merged image as pink. 
(d) Oligodendrocytes were infected with SFV containing MOG, and 
16 h after infection, cells were fixed and processed for immunofluores-
cence for MOG (red) and cholesterol (blue). Bars, 10  m.
Figure 8. Exogenously expressed PLP associates with rafts in 
primary cultures of oligodendrocytes only after increasing expression 
times. Oligodendrocytes were infected with SFV-PLP–myc or were 
left uninfected (endogenous). 8 or 16 h after infection, the cells 
were extracted with 20 mM CHAPS for 30 min at 4 C and floated 
in a density gradient. Six fractions were collected from the top 
and proteins were resolved on SDS-PAGE. After Western blotting, 
proteins were detected with anti-PLP (endogenous) or anti-myc 
(SFV-PLP–myc, 8 or 16 h) antibodies. The top fraction represents 
the low-density, CHAPS-insoluble membrane fraction, whereas the 
fractions of high density contain CHAPS-soluble membrane. 
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3) into myelin rafts in oligodendroglial precursor cells (un-
published data). These data rule out the possibility that the
viral expression system or the myc tag interferes with raft in-
corporation and suggest that raft association is reduced in
primary cultures of oligodendrocytes because the protein is
overexpressed.
In BHK cells, the continuous accumulation of PLP and
cholesterol in late endosomes/lysosomes was accompanied
by increased insolubility in CHAPS. To analyze whether the
same is true for oligodendrocytes, the cells were analyzed at
later time points after SFV-PLP–myc infection, when a sub-
stantial fraction of PLP and cholesterol had accumulated
(Fig. 7 c). Indeed, a large fraction of PLP–myc was recov-
ered from the low-density, detergent-insoluble membrane
fraction 16 h after infection (Fig. 8). Taken together, these
data show that exogenously overexpressed PLP does not as-
sociate with rafts during biosynthesis; only later, when the
protein accumulates in late endosomes/lysosomes, does raft
binding ensue.
 
PLP-overexpressing mice accumulate PLP and 
cholesterol in late endosomes/lysosomes
 
Transgenic mice with increased dosage of the PLP gene have
been useful models for PMD (Kagawa et al., 1994; Read-
head et al., 1994). These mice develop a dys- and demyelin-
ating disease, the severity of which is related to the level of
PLP overexpression. Immunocytochemistry with antibodies
against PLP/DM20 has shown that PLP/DM20 distributes
differently in transgenic mice compared with wild type
(Gow et al., 1998). PLP/DM20 is found in myelin tracts
that can be followed over a long distance through brain sec-
tions in wild-type mice, whereas PLP/DM20 localizes to
short and swollen myelin segments in transgenic mice. Fur-
thermore, PLP/DM20 was found to accumulate at a perinu-
clear location in many oligodendrocytes of the transgenic
animal (Macklin et al., 1995; Gow et al., 1998). The subcel-
lular compartment of these perinuclear accumulations has
not yet been determined. To analyze whether PLP/DM20
accumulates in late endosomes/lysosomes in PLP-overex-
pressing oligodendrocytes, we performed immunolocaliza-
tion of PLP in situ. Sagittal sections of the brain of 3-wk-old
homozygous PLP-overexpressing mice (line no. 66 in Read-
head et al., 1994) were stained with antibodies against PLP/
DM20 and LAMP-1. We found that PLP/DM20 accumu-
lated in the perinuclear region and colocalized with LAMP-1
(Fig. 9 a). Quantitative analysis of the sections indicated that
colocalization of PLP and LAMP-1 was increased 
 
 
 
10-fold
in PLP-overexpressing mice (line no. 66) compared with
age-matched wild-type control mice. When tissue sections
were labeled with filipin, we found that a significant amount
(
 
 
 
40%) of LAMP-1– and PLP-positive structures were also
labeled with filipin (Fig. 9, b and c). These results strongly
suggest that PLP overexpression in vivo also causes the pro-
teins to accumulate in late endosomes/lysosomes; thus,
our in vitro results are also relevant for the pathogenesis
of PMD.
 
Discussion
 
We found that overexpressed PLP is routed to late endo-
somes/lysosomes and causes a sequestration of cholesterol in
these compartments. This result is surprising, as unesterified
cholesterol is normally found mainly in the plasma mem-
brane, Golgi apparatus, and early or recycling endosomes
(Brotherus and Renkonen, 1977; Hornick et al., 1997;
Mukherjee et al., 1998; Gagescu et al., 2000; Kobayashi et
al., 2001; Lusa et al., 2001). Under normal conditions, in-
ternalized cholesterol taken up by the LDL receptor is rap-
idly deesterified, released into the lumen of the late endo-
some, and translocated through the activity of the NPC1
protein (Brown and Goldstein, 1986; Liscum, 2000). Inter-
nalized cholesterol present in lipid rafts is distributed to early
and recycling endosomes from where it can recycle back to
the plasma membrane. It is largely restricted from entering
the degradative compartment of the endosomal system
(Brotherus and Renkonen 1977; Hornick et al., 1997;
Mukherjee et al., 1998; Gagescu et al., 2000; Kobayashi et
al., 2001; Lusa et al., 2001; Nichols et al., 2001). Taken to-
gether, these mechanisms ensure that cholesterol levels are
kept low in late endosomes. Our results raise the question as
Figure 9. Perinuclear PLP/DM20 
localizes to late endosomes/lysosomes 
and colocalizes with cholesterol in PLP-
overexpressing transgenic mice. 3-wk-
old homozygous PLP-overexpressing 
transgenic mice were perfused, and 
sagittal sections of the brain were prepared 
and stained with antibodies against PLP/
DM20 and LAMP-1. Immunofluores-
cence staining is shown in red for PLP/
DM20 and green for LAMP-1 (a–c). 
Nuclei are visualized with DAPI and 
shown in blue in the merged image (a). 
In the merged image (a), yellow indicates 
colocalization of PLP/DM20 and LAMP-1. 
The inset represents a magnification of 
the region indicated. Cholesterol was 
labeled with filipin and shown in blue 
(b and c). Several cells are shown in the 
overview (b), whereas a single cell is 
shown in the image of higher magnifica-
tion (c). Bars, 8  m. 
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to how PLP causes accumulation of cholesterol in late endo-
somes/lysosomes. The direct interaction of PLP with choles-
terol (Simons et al., 2000) supports the view of a cotransport
of PLP and cholesterol to this compartment. Alternatively, it
may be that accumulations of PLP in the late endosomal–
lysosomal system perturb the translocation of cholesterol
from these compartments. Normally, the majority of PLP
is incorporated into cholesterol- and galactosylceramide-
enriched domains (myelin rafts) and is subsequently trans-
ported to and retained in myelin. Because the entry of rafts
into the degradative compartment of the endosomal system
is restricted, PLP might normally recycle back to the plasma
membrane when entering the endocytic system. However,
in BHK cells, possibly due to the absence of sufficient
amounts of myelin lipids such as galactosylceramide and sul-
fatide, PLP is not incorporated into rafts. Furthermore in
oligodendrocytes, exogenously overexpressed PLP also does
not associate with rafts. The increased expression of PLP
most likely saturates the available myelin raft pathway. As a
result, PLP may be routed to the degradative compartment
of the endosomal system. With time, the accumulated PLP
is increasingly insoluble in CHAPS and thus seems to be-
come raft associated. This might be due to the trapping of
other raft lipids. It is known that in lipid storage diseases,
the accumulation of one class of raft lipid within late endo-
somes/lysosomes leads to the accumulation of other raft lip-
ids. For example, in NPA and -B cells, which have a defect
in sphingomyelinase, sphingomyelin accumulation is ac-
companied by cholesterol accumulation in late endosomes/
lysosomes. Conversely, NPC cells, which accumulate choles-
terol due to a defect in the NPC1 protein, also accumulate
sphingomyelin (Pentchev et al., 1995; Puri et al., 1999; Si-
mons and Gruenberg, 2000). Thus, the primary accumula-
tion of one raft lipid can lead to the secondary accumulation
of another lipid. We suggest that insolubility of PLP at later
time points of infection reflects the formation of lipid rafts
in the degradative compartment of the endosomal system.
This conclusion is supported by our finding that increased
insolubility of PLP is accompanied by the increased insolu-
bility of cholesterol in BHK cells. In addition, we show that
two sphingolipids, BODIPY–lactosylceramide and –galacto-
sylceramide, which normally associate with the Golgi com-
plex, are redistributed to perinuclear vesicles in cells express-
ing PLP, supporting our conclusion that sphingolipids
follow the transport of PLP and cholesterol. Furthermore,
the lipid raft marker GPI–YFP also exhibits an abnormal lo-
calization in cells that express PLP.
If PLP is able to form and associate with rafts in the endo-
somal–lysosomal system of BHK cells, why is the protein
not incorporated into rafts in the Golgi complex in the first
place? The affinity of PLP to BHK rafts may be low, and
therefore PLP might not be incorporated into rafts during
the biosynthetic transport. Only after accumulation of PLP
in late endosomes and cumulative sequestration of choles-
terol and other raft lipids is association to rafts possible. It
could be that the accumulation leads to clustering of raft lip-
ids, and this in turn increases PLP association with rafts. For
example, the NPC protein is detergent soluble in normal fi-
broblasts, but in NPC cells, when lipid-rafts accumulate in
late endosomes/lysosomes, it becomes increasingly detergent
insoluble (Lusa et al., 2001). Likewise, the clustering of rafts
might also be involved in the activation of lymphoid cells
and is known to enhance the affinity of the T cell receptor to
rafts (Viola, 2001). More work will be required to elucidate
the interaction of PLP with the different raft lipids and to
define how these interactions influence the trafficking be-
havior of PLP.
What is the significance of this finding for the pathogene-
sis of PMD? There are now several lines of evidence that
PMD is a result of toxic “gain of function” of PLP, rather
than a loss of functional protein. For example, PLP knock-
out mice have a remarkably mild phenotype (Klugmann et
al., 1997), whereas missense mutations or increased gene
dosage of PLP lead to severe forms of PMD (Garbern et al.,
1999). For the missense mutations, it has been shown that
the underlying pathogenic mechanism is the accumulation
of misfolded protein in the ER (Gow and Lazzarini, 1996).
Misfolded PLP is harmful to the cell and provokes an “un-
folded protein response,” which leads to subsequent cell
death by apoptosis (Gow et al., 1998). However, for the ma-
jority of patients with PMD due to gene duplication fol-
lowed by an increased gene dosage of PLP, the molecular na-
ture of the toxic “gain of function” has remained obscure. As
a disease mechanism, we and others have proposed that PLP
overexpression results in an arrest of oligodendrocyte and
myelin development (Kagawa et al., 1994; Readhead et al.,
1994). However, these studies did not show whether ar-
rested myelin development is a direct effect of PLP expres-
sion or possibly a secondary effect due to abnormal accumu-
lation of PLP. It is unlikely that overexpression of PLP leads
to accumulation of misfolded protein in the ER, as observed
for the missense mutations. When the SFV expression sys-
tem was used, PLP was not retained in the ER of BHK cells
or oligodendrocytes. Instead, we found that overexpression
of PLP leads to the formation of detergent-insoluble accu-
mulation of cholesterol and PLP within late endosomes/ly-
sosomes. Because these raft aggregates seem to disturb raft
membrane trafficking, it is possible that they also impair the
process of myelination. Other myelin lipids may be trapped
along with PLP in late endosomes/lysosomes. The capacity
of late endosomes/lysosomes to recycle and/or degrade my-
elin membrane might also be disturbed and induce or accel-
erate the disease process. Furthermore, important signaling
molecules that are required to initiate myelination, such as
fyn, are found in rafts in oligodendrocytes (Krämer et al.,
1997). Myelination is significantly reduced in fyn-deficient
transgenic mice (Umemori et al., 1994; Sperber et al.,
2001), and morphological differentiation of oligodendro-
cytes requires activation of fyn tyrosine kinase (Osterhout et
al., 1999). It is tempting to speculate that the impairment of
raft membrane trafficking induced by overexpression of PLP
disturbs fyn signaling.
Interestingly, increased dosage of the peripheral myelin
protein 22 is involved in diseases of peripheral myelin
(Charcot-Marie tooth disease type 1 and hereditary neurop-
athy with liability to pressure palsies; Suter and Snipes,
1995). Myelinating cells may be particularly sensitive to an
imbalance in the synthesis and turnover of myelin compo-
nents due to their high rate of myelin synthesis (Pfeiffer et
al., 1993). It is likely that oligodendrocytes trigger a death 
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program early in the disease process. Indeed, mouse models
of PMD that carry extra copies of the PLP gene show that
oligodendrocytes die prematurely, i.e., as early as a few
weeks after birth depending on the levels of expression of the
PLP transcript (Kagawa et al., 1994; Readhead et al., 1994;
Inoue et al., 1996). Furthermore, we have observed that the
viability of immortalized oligodendroglial precursor cells is
reduced by 24% in cells where PLP was expressed for 20 h
with the SFV expression system, compared with cells that
expressed MOG (unpublished data). An important issue for
future studies is the mechanism of induction and execution
of cell death in PLP-overexpressing oligodendrocytes.
 
Materials and methods
 
Reagents
 
Unless otherwise stated, all chemicals were obtained from the sources de-
scribed previously by Krämer et al. (1997) and Simons et al. (2000). Filipin,
U18666A, and lipoprotein-deficient FCS were from Sigma-Aldrich. 70 kD
rhodamine–dextran, rhodamine–transferrin, BODIPY–galactosylceramide,
and BODIPY–lactosylceramide were from Molecular Probes. The follow-
ing rabbit pAbs were used: antibodies recognizing the COOH terminus of
PLP (Linington and Waehneldt, 1990), EEA1 (Simonsen et al., 1998), M6P
receptor, and the SFV protein E2. The following mouse mAbs were used:
antibodies recognizing the c-myc epitope (Sigma-Aldrich), LBPA (Koba-
yashi et al., 1998), LAMP-1 (BD PharMingen), and MOG (clone 818C5).
Secondary antibodies were from Dianova.
 
Cell culture and transfection
 
Primary cultures of oligodendrocytes were prepared and maintained as de-
scribed previously (Simons et al., 2000). The immortalized oligodendro-
glial precursor cell line (Oli-neu) was cultured as described previously
(Jung et al., 1995). BHK-21 cells were cultured in G-MEM (GIBCO BRL)
containing 5% FCS and supplemented with penicillin (100 U/ml), strepto-
mycin (100 
 
 
 
g/ml), and 2 mM glutamine (all from GIBCO BRL). Transfec-
tion of BHK cells was performed with FuGENE transfection reagents
(Roche Molecular Biochemicals) according to the manufacturer’s protocol.
 
Preparation of detergent-insoluble membrane fractions
Detergent extraction was performed as described by Simons et al. (2000)
and Brown and Rose (1992). Primary oligodendrocytes or BHK cells cul-
tured in a 5-cm dish were washed in PBS, scraped into 300  l of 50 mM
Tris-HCl, pH 7.4, 5 mM EDTA (TE), supplemented with protease inhibitors,
and extracted for 30 min by adding CHAPS (20 mM final concentration).
For lipid analysis, cells were grown in 10-cm dishes, washed, and scraped
in PBS. The cell pellet was extracted with 350  l of 20 mM CHAPS in TE
buffer. The samples were either floated in an Optiprep step gradient (40,
30, 0% Optiprep) as previously described (Simons et al., 2000) or centri-
fuged at 14,000 g for 30 min at 4 C and processed as described by Brown
and Rose (1992). The resulting fractions were processed for SDS-PAGE,
followed by immunoblotting, or for TLC as described.
DNA constructs, preparation of recombinant SFV, 
and infection of cells
For preparation of recombinant SFV, we followed the protocol of Lil-
jeström and Garoff (1991). A c-myc epitope (EQKLISEEDL) was introduced
at the COOH terminus of PLP and subcloned into the pCMV vector. The
PLP–myc, PLP, MOG, and GFP cDNA were cloned into the SmaI restric-
tion site of pSFV1. pSFV1 was linearized using Nru1, pSFV-helper 1 using
Spe1, and runoff transcription was performed with SP6 RNA polymerase.
The transcription mix was cotransfected with the helper–transcription mix
into BHK cells using electroporation. The culture supernatant was col-
lected after a 24-h incubation (5% CO2, 37 C). The virus-containing super-
natant was titrated on BHK cells. For infection, cells were incubated for 1 h
with recombinant SFV diluted in conditioned maintenance medium (5%
CO2, 37 C). The virus was replaced by maintenance medium and the in-
fection continued for 5–20 h.
Lipid analysis
To analyze de novo cholesterol synthesis, BHK cells grown in 5-cm dishes
were infected with SFV-PLP–myc or SFV-GFP or were left uninfected. 16 h
after infection, cells were labeled with [
14C]acetate (50  Ci/ml) for 4 h in
G-MEM containing 5% lipoprotein-deficient FCS and chased for 2 h in
normal medium. Cells were scraped into ice-cold PBS, harvested by cen-
trifugation, and resuspended in 2% NaCl. To analyze total cholesterol lev-
els or CHAPS insolubility of cholesterol, cells were infected for 20 h or left
uninfected and processed as described above. Lipids were extracted, sepa-
rated, and quantified as described by Simons et al. (2000). Cholesterol ef-
flux was performed essentially as detailed by Lusa et al. (2001). BHK cells
were labeled with 0.5  Ci/ml [
14C]cholesterol in G-MEM containing 5% li-
poprotein-deficient FCS for 24 h, infected or not, and incubated for 20 h in
the absence of label in normal maintenance medium. Efflux to 10 mM
m Cd was performed on ice for 30 min in serum-free medium. Medium
was removed, cells were harvested in 2% NP-40, 0.2% SDS in TE, and the
radioactivity was determined in both fractions by liquid scintillation count-
ing. BODIPY–galactosylceramide and –lactosylceramide were added to
cells as a BSA complex, and cells were cultured for 45 min at 37 C in cul-
ture medium (Puri et al., 1999). They were then washed and further incu-
bated for 1 h at 37 C in culture medium. Fluorescent lipid present at the
plasma membrane was then removed by washing six times with 3% defat-
ted BSA at 12 C (“back exchange”) (Martin and Pagano 1994).
Immunocytochemistry
Cells were fixed with 4% paraformaldehyde in PBS, pH 7.4, permeabilized
with 0.1% Triton X-100 at room temperature (RT) or on ice for 30 s for fil-
ipin stainings, and blocked in 2% FCS and 0.2% gelatin in PBS. The cells
were incubated in the presence of primary antibody for 1 h at RT, washed
three times for 5 min with PBS, incubated with the appropriate secondary
antibodies, washed again, and mounted. For filipin labeling, cells were in-
cubated for 20 min at RT with filipin diluted in PBS (0.5 mg/ml), washed
two times for 5 min in PBS, and mounted. Fluorescent images were ob-
tained using Axiophot (ZEISS) or a confocal microscope (TCS confocal sys-
tem; Leica). For immunocytochemistry on brain sections, mice were anes-
thetized and fixed by vascular perfusion with 4% paraformaldehyde in 0.1 M
sodium phosphate, pH 7.2. Brains were dissected and infiltrated with
20% sucrose in phosphate buffer at 4 C before cryostat sectioning. Frozen
sections (10–20  m) were mounted, permeabilized for 10 min with metha-
nol ( 20 C), and labeled with primary antibody (overnight at RT) and the
respective secondary antibody (4 h at RT). For filipin labeling, sections
were incubated in quenching solution (1.5 mg/ml glycine, 1% BSA, 0.02%
saponin–PBS) at RT for 30 min. This was followed by incubating sections
with filipin (0.005 mg/ml) for 10 min in the dark while shaking. Cells that
showed colocalization of PLP and LAMP-1 were counted from 50 random
fields from four different sagittal sections of wild-type or transgenic mice.
119 cells were counted from the sections of the transgenic animal, and 8
cells were counted from the sections of the wild-type animal.
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